217 related articles for article (PubMed ID: 28186102)
1. Cancer cell-secreted IGF2 instigates fibroblasts and bone marrow-derived vascular progenitor cells to promote cancer progression.
Xu WW; Li B; Guan XY; Chung SK; Wang Y; Yip YL; Law SY; Chan KT; Lee NP; Chan KW; Xu LY; Li EM; Tsao SW; He QY; Cheung AL
Nat Commun; 2017 Feb; 8():14399. PubMed ID: 28186102
[TBL] [Abstract][Full Text] [Related]
2. Id1-induced IGF-II and its autocrine/endocrine promotion of esophageal cancer progression and chemoresistance--implications for IGF-II and IGF-IR-targeted therapy.
Li B; Tsao SW; Chan KW; Ludwig DL; Novosyadlyy R; Li YY; He QY; Cheung AL
Clin Cancer Res; 2014 May; 20(10):2651-62. PubMed ID: 24599933
[TBL] [Abstract][Full Text] [Related]
3. Competitive Binding Between Id1 and E2F1 to Cdc20 Regulates E2F1 Degradation and Thymidylate Synthase Expression to Promote Esophageal Cancer Chemoresistance.
Li B; Xu WW; Guan XY; Qin YR; Law S; Lee NP; Chan KT; Tam PY; Li YY; Chan KW; Yuen HF; Tsao SW; He QY; Cheung AL
Clin Cancer Res; 2016 Mar; 22(5):1243-55. PubMed ID: 26475334
[TBL] [Abstract][Full Text] [Related]
4. Addiction to the IGF2-ID1-IGF2 circuit for maintenance of the breast cancer stem-like cells.
Tominaga K; Shimamura T; Kimura N; Murayama T; Matsubara D; Kanauchi H; Niida A; Shimizu S; Nishioka K; Tsuji EI; Yano M; Sugano S; Shimono Y; Ishii H; Saya H; Mori M; Akashi K; Tada KI; Ogawa T; Tojo A; Miyano S; Gotoh N
Oncogene; 2017 Mar; 36(9):1276-1286. PubMed ID: 27546618
[TBL] [Abstract][Full Text] [Related]
5. IGF2 induces CD133 expression in esophageal cancer cells to promote cancer stemness.
Xu WW; Li B; Zhao JF; Yang JG; Li JQ; Tsao SW; He QY; Cheung ALM
Cancer Lett; 2018 Jul; 425():88-100. PubMed ID: 29604392
[TBL] [Abstract][Full Text] [Related]
6. Interaction between IGF2-PI3K axis and cancer-associated-fibroblasts promotes anal squamous carcinogenesis.
Cacheux W; Lièvre A; Richon S; Vacher S; El Alam E; Briaux A; El Botty R; Mariani P; Buecher B; Schnitzler A; Barbazan J; Roman-Roman S; Bièche I; Dangles-Marie V
Int J Cancer; 2019 Oct; 145(7):1852-1859. PubMed ID: 30714617
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA 91H contributes to the occurrence and progression of esophageal squamous cell carcinoma by inhibiting IGF2 expression.
Gao T; He B; Pan Y; Xu Y; Li R; Deng Q; Sun H; Wang S
Mol Carcinog; 2015 May; 54(5):359-67. PubMed ID: 24706416
[TBL] [Abstract][Full Text] [Related]
8. Stromal-derived IGF2 promotes colon cancer progression via paracrine and autocrine mechanisms.
Unger C; Kramer N; Unterleuthner D; Scherzer M; Burian A; Rudisch A; Stadler M; Schlederer M; Lenhardt D; Riedl A; Walter S; Wernitznig A; Kenner L; Hengstschläger M; Schüler J; Sommergruber W; Dolznig H
Oncogene; 2017 Sep; 36(38):5341-5355. PubMed ID: 28534511
[TBL] [Abstract][Full Text] [Related]
9. The crucial role of miR-126 on suppressing progression of esophageal cancer by targeting VEGF-A.
Kong R; Ma Y; Feng J; Li S; Zhang W; Jiang J; Zhang J; Qiao Z; Yang X; Zhou B
Cell Mol Biol Lett; 2016; 21():3. PubMed ID: 28536606
[TBL] [Abstract][Full Text] [Related]
10. [The potential role of Id1 in COX-2 mediated angiogenesis in gastric cancer].
Lei T; Han S; Guo XY; Ding R; Li Y; Xie HH; Bai FH; Wu KC; Ding J
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(22):1570-5. PubMed ID: 17785115
[TBL] [Abstract][Full Text] [Related]
11. miR-30e targets IGF2-regulated osteogenesis in bone marrow-derived mesenchymal stem cells, aortic smooth muscle cells, and ApoE-/- mice.
Ding W; Li J; Singh J; Alif R; Vazquez-Padron RI; Gomes SA; Hare JM; Shehadeh LA
Cardiovasc Res; 2015 Apr; 106(1):131-42. PubMed ID: 25678587
[TBL] [Abstract][Full Text] [Related]
12. Regulation of angiogenesis by Id-1 through hypoxia-inducible factor-1alpha-mediated vascular endothelial growth factor up-regulation in hepatocellular carcinoma.
Lee TK; Poon RT; Yuen AP; Ling MT; Wang XH; Wong YC; Guan XY; Man K; Tang ZY; Fan ST
Clin Cancer Res; 2006 Dec; 12(23):6910-9. PubMed ID: 17145808
[TBL] [Abstract][Full Text] [Related]
13. p53 functional deficiency in human colon cancer cells promotes fibroblast-mediated angiogenesis and tumor growth.
Hayashi Y; Tsujii M; Kodama T; Akasaka T; Kondo J; Hikita H; Inoue T; Tsujii Y; Maekawa A; Yoshii S; Shinzaki S; Watabe K; Tomita Y; Inoue M; Tatsumi T; Iijima H; Takehara T
Carcinogenesis; 2016 Oct; 37(10):972-984. PubMed ID: 27520561
[TBL] [Abstract][Full Text] [Related]
14. BMP2 and VEGF promote angiogenesis but retard terminal differentiation of osteoblasts in bone regeneration by up-regulating Id1.
Song X; Liu S; Qu X; Hu Y; Zhang X; Wang T; Wei F
Acta Biochim Biophys Sin (Shanghai); 2011 Oct; 43(10):796-804. PubMed ID: 21880603
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor mediates intracrine survival in human breast carcinoma cells through internally expressed VEGFR1/FLT1.
Lee TH; Seng S; Sekine M; Hinton C; Fu Y; Avraham HK; Avraham S
PLoS Med; 2007 Jun; 4(6):e186. PubMed ID: 17550303
[TBL] [Abstract][Full Text] [Related]
16. Possible involvement of tumor-producing VEGF-A in the recruitment of lymphatic endothelial progenitor cells from bone marrow.
Tawada M; Hayashi S; Ikegame Y; Nakashima S; Yoshida K
Oncol Rep; 2014 Dec; 32(6):2359-64. PubMed ID: 25242215
[TBL] [Abstract][Full Text] [Related]
17. IGF2 DMR0 methylation, loss of imprinting, and patient prognosis in esophageal squamous cell carcinoma.
Murata A; Baba Y; Watanabe M; Shigaki H; Miyake K; Ishimoto T; Iwatsuki M; Iwagami S; Yoshida N; Oki E; Morita M; Nakao M; Baba H
Ann Surg Oncol; 2014 Apr; 21(4):1166-74. PubMed ID: 24318096
[TBL] [Abstract][Full Text] [Related]
18. Impact of VEGF-dependent tumour micro-environment on EDB fibronectin expression by subcutaneous human tumour xenografts in nude mice.
Coltrini D; Ronca R; Belleri M; Zardi L; Indraccolo S; Scarlato V; Giavazzi R; Presta M
J Pathol; 2009 Dec; 219(4):455-62. PubMed ID: 19824060
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-100 shuttled by mesenchymal stem cell-derived exosomes suppresses in vitro angiogenesis through modulating the mTOR/HIF-1α/VEGF signaling axis in breast cancer cells.
Pakravan K; Babashah S; Sadeghizadeh M; Mowla SJ; Mossahebi-Mohammadi M; Ataei F; Dana N; Javan M
Cell Oncol (Dordr); 2017 Oct; 40(5):457-470. PubMed ID: 28741069
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor receptor 1 (VEGFR1) tyrosine kinase signaling facilitates granulation tissue formation with recruitment of VEGFR1
Park K; Amano H; Ito Y; Mastui Y; Kamata M; Yamazaki Y; Takeda A; Shibuya M; Majima M
Anat Sci Int; 2018 Jun; 93(3):372-383. PubMed ID: 29256114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
